Divergent Low Level Laser Therapy as novel treatment for oral mucositis in patients with oral or oropharyngeal squamous cell carcinoma’

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON21094

Enrollment

Registered

2019-07-10

Start date

2019-09-02

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Oral mucositis in oral or oropharyngeal squamous cell carcinoma

Interventions

Divergent low level laser therapy

Eligibility

Inclusion criteria

Inclusion criteria: In order to be eligible to participate in this study, a subject must meet all of the following criteria: • Subjects should have a primary O/OPSCC • Subjects who are scheduled for RT • Subjects who are competent • Subjects should be aged 18 years or older

Exclusion criteria

Exclusion criteria: A potential subject who meets any of the following criteria will be excluded from participation in this study: • O/OPSCC recurrence after primary O/OPSCC treatment • Unable to read Dutch • Unable to complete the questionnaires

Design outcomes

Primary

Measure	Time frame
The severity of oral mucositis	—

Secondary

Measure	Time frame
o the number of days with OM (M0-M9) o the number of oral infections (M0-M9) o oral hygiene (M0-M9) o pain (VASpain; M0-M9) o xerostomia (M0, M4, M8, and M9) o maximum mouth opening (MMO) (M0, M4, M8, and M9) o taste (M0, M4, M8, and M9) o quality of life (M0, M4, M8, and M9)	—

Contacts

Public ContactCaroline Speksnijder

UMC Utrecht

c.m.speksnijder@umcutrecht.nl+31-887568040

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)